Fig. 2: OS, OS1 and OS2 in mCRC patients with dMMR. | British Journal of Cancer

Fig. 2: OS, OS1 and OS2 in mCRC patients with dMMR.

From: Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

Fig. 2

Predicted overall survival (OS) using Kaplan–Meier curves with confidence intervals, examined for the cohort as a whole and in patients who received systemic treatment. a OS from metastatic disease in the unselected dMMR cohort (n = 279), stratified by having received antitumour therapy (n = 207) versus no antitumour therapy (n = 72), b Overall survival from first-line systemic therapy initiation (OS1) in first-line patients (n = 170), c Overall survival from second-line systemic therapy initiation (OS2) in second-line patients (n = 70). The risk tables display the number of patients at risk and the number of censored patients. Median survival is indicated with a vertical dashed line in each plot and is indicated with 95% confidence interval lower and upper ranges in the legend.

Back to article page